SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
The Guggenheim Against the Trend: Salesforce, Inc. (CRM.US) valuation is wrongly killed by "SaaS Doomsday," AI is pressure rather than a death knell.
Anchor AI supply chain main channel, DC Holdings (00861) delivers a high-quality performance in the first half of the year.
Kroger Co. (KR.US) restarts large-scale acquisitions, can it fill the gap left by the failure of the Albertsons Companies, Inc. Class A transaction?
The Guggenheim Against the Trend: Salesforce, Inc. (CRM.US) valuation is wrongly killed by "SaaS Doomsday," AI is pressure rather than a death knell.
Anchor AI supply chain main channel, DC Holdings (00861) delivers a high-quality performance in the first half of the year.
Kroger Co. (KR.US) restarts large-scale acquisitions, can it fill the gap left by the failure of the Albertsons Companies, Inc. Class A transaction?
RECOMMEND
